Emcure Pharmaceuticals Limited (NSE:EMCURE)
India · Delayed Price · Currency is INR 1,934.00
-9.00 (-0.46%)
Oct 1, 2026, 3:29 PM IST
Emcure Pharmaceuticals Market Cap
Emcure Pharmaceuticals has a market cap or net worth of 368.85 billion as of October 1, 2026. Its market cap has increased by 52.03% in one year.
Market Cap
368.85B
Enterprise Value
382.86B
Revenue
96.83B
Ranking
n/a
PE Ratio
36.45
Stock Price
1,934.00
ChartMarket Cap Chart
Since July 10, 2024, Emcure Pharmaceuticals's market cap has increased from 256.95B to 368.85B, an increase of 43.55%. That is a compound annual growth rate of 17.62%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 1, 2026 | 368.85B | 42.59% |
| Dec 31, 2025 | 258.67B | -5.64% |
| Dec 31, 2024 | 274.13B | 6.68% |
| Jul 10, 2024 | 256.95B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Glenmark Pharmaceuticals | 688.99B |
| Alkem Laboratories | 618.75B |
| Ipca Laboratories | 486.93B |
| Gland Pharma | 477.74B |
| Ajanta Pharma | 440.42B |
| Wockhardt | 355.47B |
| Piramal Pharma | 274.61B |
| Cohance Lifesciences | 173.42B |